WES demonstrated that autochthonous p53/MCA sarcomas in Rag2−/− mice harbored nearly twice the number of nonsynonymous mutations compared to primary sarcomas from immune-competent Rag2+/− mice (Fig. 2d). This evidence concerns the gene RAG2 and sarcoma.